AXGN Axogen, Inc.
Axogen, Inc. (AXGN) is expected to report earnings on October 28, 2026, before the market open. The consensus earnings estimate is a loss of $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +27.2% since its last earnings release on July 29, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Axogen, Inc.
Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair.
Sector
Healthcare
Industry
Medical Appliances/Equipment